Literature DB >> 7881652

The influence of increased bronchial responsiveness, atopy, and serum IgE on decline in FEV1. A longitudinal study in the elderly.

M Tracey1, A Villar, L Dow, D Coggon, F C Lampe, S T Holgate.   

Abstract

We have performed a 4-yr prospective survey of the association of allergen skin test positivity, total serum immunoglobulin E (IgE), and bronchial responsiveness to methacholine, with longitudinal decline in FEV1, in subjects over 65 yr of age. In 1987, 324 subjects completed a respiratory questionnaire, and underwent measurement of FEV1 and FVC, methacholine challenge, skin prick testing (to Dermatophagoides pteronyssinus, cat fur, mixed grasses, and Aspergillus fumigatus) and estimation of total serum IgE. After an interval of 4 yr, 212 subjects were reexamined. The mean annual decline in FEV1 was significantly higher in males than in females, but was not significantly influenced by smoking habits defined at the start of the study. The relation of atopy (skin test reaction to allergen > or = 3 mm greater than saline control), increased bronchial responsiveness (PD20FEV1 < or = 6.4 mumoles methacholine) and serum IgE > 80 IU/ml, to annual decline in FEV1 was examined for each risk factor individually with adjustment for age, sex, height, and initial FEV1, by multiple linear regression. Both atopy and bronchial responsiveness were significantly associated with accelerated decline in FEV1. Elevated IgE was correlated with faster FEV1 decline in subjects who were current smokers at the start of the study. In a multiple regression model examining the mutually adjusted associations of all relevant variables with annual decline in FEV1, male sex was the most important predictor (B = 38.6 ml/yr, 95% Cl = 4.3, 72.9). Increased bronchial responsiveness also tended to be associated with accelerated decline in FEV1. In further analyses incorporating the same variables, but restricted to specific smoking categories, age was the only significant factor in the never-smokers, whereas both atopy (B = 44.5 ml/yr, 95% Cl = 3.8, 85.3) and increased bronchial responsiveness (B = 43.5 ml/yr, 95% Cl = 4.6, 82.3) were significant predictors of accelerated FEV1 decline in former and current smokers combined.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7881652     DOI: 10.1164/ajrccm/151.3_Pt_1.656

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  15 in total

1.  Lung function decline in laboratory animal workers: the role of sensitisation and exposure.

Authors:  L Portengen; A Hollander; G Doekes; G de Meer; D Heederik
Journal:  Occup Environ Med       Date:  2003-11       Impact factor: 4.402

Review 2.  Health effects of passive smoking. 8. Passive smoking and risk of adult asthma and COPD: an update.

Authors:  D B Coultas
Journal:  Thorax       Date:  1998-05       Impact factor: 9.139

Review 3.  Benefits and risks of inhaled corticosteroids in chronic obstructive pulmonary disease.

Authors:  Marcel Bonay; Catherine Bancal; Bruno Crestani
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

4.  Generic Respiratory Symptoms and Branded Lung Diseases. Same Difference?

Authors:  Surya P Bhatt
Journal:  Am J Respir Crit Care Med       Date:  2018-06-15       Impact factor: 21.405

Review 5.  Update on the "Dutch hypothesis" for chronic respiratory disease.

Authors:  J Vestbo; E Prescott
Journal:  Thorax       Date:  1998-08       Impact factor: 9.139

6.  Polymorphisms in the beta2 adrenergic receptor and bronchodilator response, bronchial hyperresponsiveness, and rate of decline in lung function in smokers.

Authors:  L Joos; T D Weir; J E Connett; N R Anthonisen; R Woods; P D Paré; A J Sandford
Journal:  Thorax       Date:  2003-08       Impact factor: 9.139

Review 7.  The role of lung inflation in airway hyperresponsiveness and in asthma.

Authors:  Nicola Scichilone; Alkis Togias
Journal:  Curr Allergy Asthma Rep       Date:  2004-03       Impact factor: 4.806

8.  Relationship of serum IgE concentration to level and rate of decline of pulmonary function: the Normative Aging Study.

Authors:  N A Shadick; D Sparrow; G T O'Connor; D DeMolles; S T Weiss
Journal:  Thorax       Date:  1996-08       Impact factor: 9.139

Review 9.  Systematic review of the evidence relating FEV1 decline to giving up smoking.

Authors:  Peter N Lee; John S Fry
Journal:  BMC Med       Date:  2010-12-14       Impact factor: 8.775

10.  Atopy is a risk factor for respiratory symptoms in COPD patients: results from the EUROSCOP study.

Authors:  Fatemeh Fattahi; Nick H T ten Hacken; Claes-Göran Löfdahl; Machteld N Hylkema; Wim Timens; Dirkje S Postma; Judith M Vonk
Journal:  Respir Res       Date:  2013-01-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.